ReCor Medical raises $15M for ultrasound RDN

ReCor Medical raises a $15 million Series D financing for a planned U.S. study of its ultrasound renal denervation device.

A Japanese healthcare conglomerate is the lead investor ReCor Medical's $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.

ReCor Medical

News Well, Clinical Trials, Hypertension, Funding Roundup, Renal

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://www.massdevice.com/news/recor-medical-raises-15m-ultrasound-rdn